Proppants Market by Product, By Application is Expected To Reach 96.03 Million Tons By 2020

Global Proppants Market is expected to reach 96.03 million tons by 2020, according to a new study by Grand View Research, Inc. Growing drilling and completion activities for shale gas in the U.S. and Canada is expected to drive market growth over the next six years. In, addition advent of multiple stage fracturing resulting in higher consumption of proppants per stage is expected augment demand over the forecast period. In addition, large technically recoverable shale gas reserves in China, Australia, Algeria and Russia is expected to promote market growth.

Sand was the largest product segment accounting for over 75% of market share in 2013. Sand is expected to witness demand growth owing to its low cost and high availability in comparison to other proppants. Ceramic proppants are expected to witness significant demand growth over the next six years on account of superior properties including high strength, crush resistance and conductivity resulting in increased use for shale plays.

To request a sample copy or view summary of this report:
http://www.grandviewresearch.com/industry-analysis/proppants-market

Further key findings from the study suggest:

• Shale gas was the largest application segment in 2013 and is expected to witness swift growth over the forecast period due to large recoverable reserves in China, U.S., Algeria, Argentina, Mexico and Australia. Increasing application scope of proppant in shale gas extraction on account of the latter being used in transportation and power generation is expected to propel market growth over the forecast period.
• North America was the largest regional market, accounting for over 75% of global demand in 2013. The market is expected to witness significant growth over the next six years owing to growth in shale gas production coupled with increase in fracturing jobs per year.
• Asia Pacific is expected to witness fastest growth, at an estimated CAGR of over 12% from 2014 to 2020, owing to high potential of shale gas reserves in China coupled with large coal bed methane reserves in Australia. Regional growth can be attributed to favorable government policies to develop shale gas reserves in India and China.
• Key market participants include U.S. Silica, Carbo Ceramics, Momentive, Fairmount Santrol, Hi Crush LP Partners, Fores, Saint-Gobain and Preferred Sands. Preferred Sands and Dow Chemicals Company announced the production of an effective proppant solution that meets OSHA standard and limits silica dust exposures. Various companies focus on technological advancements to produce eco-friendly proppants which would offer increased fracture flow capacity and enhance hydrocarbon recovery.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-proppants-market 

Rapid Increase in Computer Aided Detection Market - Key Factors, Market Segments Regions and Industry Forecasts Analysis to 2022

Global computer aided detection market is expected to reach USD 1.9 billion by 2022, according to a new report by Grand View Research Inc. CAD software tools have been introduced to support radiologists to cope with the growing number of images requiring interpretation. Increasing incidence rate of breast, prostate and lung cancer, rising technological advancements, and increasing use of CAD with other imaging modalities such as ultrasound and magnetic resonance imaging are expected to serve this industry as high-impact rendering drivers. 

In the U.S., prostate cancer is one of the most common cancers amongst men and has increased the demand for multi-parametric Magnetic Resonance Imaging (MP-MRI) CADx systems for diagnosis and detection of prostate cancer. 

In screening mammography, the traditional concept of double reading by the second clinician is expected to be replaced by CAD, of breast cancer completely. This is due to the additional reimbursement generated by computer-aided detection unlike the double readings that demand more of radiologists’ time without any reimbursement for the second read. 

Wide research has been undertaken to come up with new findings establishing the relation of cancer with anatomy. For instance, Johns Hopkins researchers established the presence of dense clumps of bacteria in ascending colon to cancer. 

CAD is most widely used for breast cancer imaging due to a higher incidence of cancer in women with morbidity of 14 million new cases and 8.2 deaths according to the WHO 2012. With the increasing demand for imaging and the growing rate of chronic diseases, the demand for imaging technologies is expected to increase. Computer aided detection is now used with other imaging modalities such as ultrasound, nuclear imaging, magnetic resonance imaging, etc. 

In 2014, mammography dominated the industry as the prevalence of cancer is high and is the leading cause of morbidity and mortality. According to the World Cancer Research Fund International 2012, North America and Oceania have the highest incidence rate of breast cancer and Asia and Africa has the lowest. 

Digital imaging technique advancements are the other contributing factors for market growth as it has increased ease-of-integration of CAD solutions with imaging equipment and has also improved the efficiency of computer aided detection solutions.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/computer-aided-detection-market

Further key findings from the study suggest:

• In 2014, mammography dominated the market due to the fact that it has high potential for breast cancer imaging and was one of the first segments in which companies developed CAD software and till date most of it is working on this indication.
• According to the WHO data 2012, there were 14 million new cases of breast cancer. The increasing awareness has led increase in regular cancer check-ups as a preventive step.
• The demand for CAD has grown in chest imaging such as low-dose lung cancer screening due to Multidetector Computed Tomography (MDCT) indications. Furthermore, CAD has been brought in use for established areas of chest CT such as diagnosis of interstitial lung disease and acute Pulmonary Embolism (PE).
• CAD is also used with other imaging modalities such as x-ray, computed tomography, and ultrasound. Out of these, the use of CAD for x-ray imaging is the highest as it is the basic imaging and due to the recent advances overcoming its limitations of soft tissue imaging.
• North America was the most revenue generating region of the market. The market contributed more than 40% of the revenue in 2014. Constant efforts to fuel the market with newer technologies and the use of computer aided detection for integrative diagnosis apart from image analysis are expected to drive regional market growth over the forecast period.
• Asia Pacific and Europe are expected to spearhead future market growth due to the availability of cost-effective technologies and rise in medical tourism. UK cancer patients mostly treat themselves in Eastern Europe, Germany, France, and Spain as these nations specialize in cancer treatments, and as flights to these destinations are relatively cheaper and consume lesser time.
• Key market players are EDDA Technology, Inc., FUJIFILM Medical Systems, Hitachi High Technologies Corporation, Hologic Inc., iCAD, Inc., Vucomp, McKesson Corporation, Philips Healthcare, Siemens Healthcare, and Toshiba Medical Systems Corporation. 

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-computer-aided-detection-market  

Bioprosthetics Market Expand Their Businesses With New Investments

The global bioprosthetics market is expected to reach USD 6.41 billion by 2024, according to a new report by Grand View Research, Inc. The unprecedented upward shift in the lifestyle-associated habits leading to the high prevalence of cardiovascular diseases coupled with the increasing geriatric population base,which is highly susceptible to developing cardiac impairments and tissue damage,are presumed to impel the demand for the bioprosthetics market during the forecast period.

Lower biocompatibility, aesthetics, and strength exhibited by the synthetic material-based prosthetics indicate the indisputable requirement for incorporating bioprosthetics; consequentially, the increasing need for the tissue-engineered autologous, allogenic or xenograft products is anticipated to present the market with lucrative growth opportunities.

The growth in the demand for bioprostheses is attributed mainly to technological advancements comprising trans catheter valve fabrication technology, the construction of which involves a multidisciplinary approach, wherein wide-ranging technologies borrowed from varied devices including balloon angioplasty and coronary stents as well as medical disciplines, such as cardiac surgery and interventional cardiology, are merged to introduce a revolutionary quantum leap in the transcatheter valve replacement procedures. Moreover, a combination of the non-invasive imaging techniques, such as, echo cardiography angiography, MRI, and CT, are increasingly being employed, which allows the surgeons to visualize both the device and the anatomy of the patient thus eliminating the need to conduct an open heart surgery.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/bioprosthetics-market

Further key findings from the study suggest:

• The allograft segment is expected to exhibit growth at a significant CAGR of over 10.0% during the forecast period. This is a consequence of the following associated advantages such as reduced surgical time, smaller incisions, greater physiological acceptability, availability of larger grafts, and a safer alternative to procedures that employ synthetic grafts as they pose a high risk of complications under anesthesia
• The plastic surgery and wound healing segment is anticipated to witness an exponential CAGR of over 11.0% in the application segment over the forecast period. This substantial share can be attributed to the increasing number of soft tissue repair procedures, such as in hernia and abdominal wall reconstruction
• Additionally, as per a research published by the NCBI, the increase in case complexities drive the need to apply a multidisciplinary approach in performing the above-mentioned procedures, which augments the use of these bioprosthetics meshes to decrease the morbidity associated with chronic impairments
• In 2015, Europe dominated the overall bioprosthetics market at over 40.0%. Moreover, the subsequent changes in the demographic trends, such as the frequent product approvals, increasing geriatric population base, lifestyle-associated changes, and the high awareness levels pertaining to the availability of bioprosthetics solutions are anticipated to drive the market growth in this region
• For instance, In April 2016, St. Jude Medical, Inc. announced the European launch of Trifecta Surgical Valve to provide enhanced alternatives to patients requiring aortic valve replacements. This launch resulted in the expansion of the existing product portfolio of St. Jude Medical, Inc. in Europe
• Some leading players in this industry include Edwards Lifesciences Corporation, St.Jude Medical, Inc., Sorin Group, CryoLife, Inc., Braile Biomedica, Inc., and Medtronic Plc; these players are increasingly involved in adopting collaborative strategies and launching frequent product approvals to facilitate business expansion
• For instance, in March 2016, Edwards Lifesciences Corporation received an approval for the SAPIEN 3 Valve in Japan for the treatment of patients suffering from aortic stenosis. Additionally, the rising involvement of the players in this vertical toward developing and enhancing the supply of bioprosthetics through strategic alliances is likely to provide the market with a high potential growth platform in the future

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-bioprosthetics-market

The Future Growth Status of the Photonics Market

The global photonics market size is expected to reach USD 979.90 billion by 2024, according to a new report by Grand View Research, Inc. The prospects for market growth can be attributed to rapid innovations in the industry for the development of technologically-enhanced products and related services, as well as growing opportunities for the new market development.

Photonics is regarded as one of the Key Enabling Technologies (KETs) in the recent past, leading to the development of new products and services with substantial economic benefits. The broad diversity of devices with photonic-based components is expected to impact the global demand for this technology positively. Photonics is a technologically advanced field, being at the forefront of innovation and R&D and is thus presumed to incorporate substantial growth prospects over the forecast period.

The industry encompasses a broad scope of applications based on photonic-based products, which are anticipated to drive the dynamic emergence of new economic activities in the potential markets. The emergence of green and sustainable photonic-based solutions, such as Photovoltaic (PV) solar cells, is envisioned to drive the industry over the forecast period, owing to the increasing support by both local governments and consumers.

The industry encompasses substantial opportunities for growth over the next eight years. The key impact of photonics technology on energy supply is presumed to offer enhanced PV efficiency in the next-generation solar cells to make PV cost-competitive with fossil fuel electricity generation. Advanced products, such as polycrystalline silicon PV, thin film PV, dye-sensitized PV, and further new developments, such as embedding nanoparticles into solar cells and nanostructure substrates, are expected to boost the demand for photonic components in renewable energy sources over the forecast period.

However, significant initial investments and absence of proper international standards in the technology are expected to challenge the industry growth over the forecast period. The high cost of technology and risk of thermal effect have led to the limited commercialization of this technology worldwide. Moreover, technology obsolescence and growing presence of counterfeit technologies across the globe are anticipated to challenge the industry growth in the near future.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/photonics-market

Further key findings from the report suggest:

• Light Emitting Diodes (LEDs) accounted for approximately 10% of the overall market share in 2015 and are presumed to grow at a considerable rate over the forecast period owing to the introduction of new legislations and policies worldwide to boost the adoption of highly efficient and renewable energy devices. LEDs are energy-efficient, high-performance, and environment-friendly alternatives to traditional light bulbs. Further developments alongside organic and inorganic LEDs, such as light emitting nanowires and quantum dots, and large areas light-emitting plastics, are presumed to boost the demand over the next eight years.
• Lasers are anticipated to witness a substantial growth over the forecast period, growing at an estimated CAGR of over 7% from 2016 to 2024. The growth in this segment can be primarily attributed to rapid developments in the industry to incorporate miniature laser projection units as a light source in next-generation pico-projectors. Lasers are being increasingly used in the production of textiles and clothing as well as fine chemicals and pharmaceuticals.
• Displays are anticipated to emerge as a predominant application segment over the next eight years owing to increasing developments of sharper, better color, energy-efficient, cheaper, and thin display devices. The increasing adoption of flexible displays, miniaturized displays, holographic displays, enhanced touch, and motion feedback displays are anticipated to lead to new product development and enhancement of existing products.
• In terms of revenue, North America dominated the global photonics market in 2015 and is expected to retain its dominance over the forecast period. The demand in this region is mainly driven by the increasing adoption of advanced technologies. The U.S. is presumed to encompass significant investments in the form of public spending and government funding for the R&D of photonic-enabled technologies. Europe is presumed to witness a considerable growth over the forecast period, owing to the growing establishment of research facilities for further development of this technology.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-photonics-market

Rising demand for Hemophilia is expected to be the key drivers for Pharmaceuticals Market

Global hemophilia market is expected to reach USD 15.2 billion by 2024, according to a new report by Grand View Research, Inc. Increasing need for diagnosis of the target population in order to initiate prophylaxis treatment and supportive government programs is expected to be the vital impact rendering driver. 

The market players are predicted to adopt strategies such as pipeline product development and geographic expansion in underdeveloped and developing regions, such as Middle Eastern and West African countries.

As of 2015, federal bodies such as the World Federation Hemophilia have vast information and treatment regulation in about 172 countries, of which 20 were added in 2013,including Nigeria, Togo, Mali, Zambia, Mauritania, and others. 

Competitive pricing strategy is a vital factor promoting market players’ growth over the forecast period. For instance, Biogen launched Eloctate in 2014 in the U.S. at a lower price than the existing vastly used drug Advate.  

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/hemophilia-treatment-industry

Further Key Findings From the Study Suggest:

• Hemophilia B is expected to grow at a rapid rate of over 6.0% during the forecast period. Higher emphasis on pipeline products with an extended half-life and increasing incidence of hemophilia B affected patients are expected to be the prominent growth factors. 
• On-demand treatment dominated the segment over the forecast period and is expected to contribute more than 50.0% by 2024. However, prophylaxis is expected to be the fastest growing segment because of the requirement for better control of bleeding episodes and growing financial assistance programs by healthcare providers and industry players. 
• For instance, Grifols has launched the “AlphaNine SD Copay Card” and “ALPHANATE Copay Program” for immediate enrollment in prophylaxis treatment by patients. 
• On the basis of therapy, gene therapy is expected to be the fastest growing segment as a result of increasing R&D and innovations in the field. Furthermore, replacement therapy is expected to witness lucrative growth due to the launch of extended half-life versions of currently available drugs. 
• For instance, Novo Nordisk is working on N8-GP, CSL Behring is working on CSL689 rVIIa-FP, and Bayer is working on BAY 94-9027.These are expected to be commercially available around 2017/2018. This is expected to improve treatment over the forecast period thereby boosting growth. 
• Major market players include Biogen, Novo Nordisk, Baxalta, Octapharma, CSL Behring, Pfizer, Inc., and Bayer Healthcare. Most of the companies are actively involved in the awareness and treatment programs launched by regional governments and hemophilia associations. Majority of their products that are awaiting FDA approval have extended therapeutic use in adults as well as children. 

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-hemophilia-market

Cardiovascular Devices Market is anticipated to reach USD 121 billion by 2024

Global cardiovascular devices market is anticipated to reach USD 121 billion by 2024, according to a new report by Grand View Research, Inc. Increasing geriatric population, sedentary life style coupled with unhealthy dietary habits is spurring the prevalence of cardiovascular diseases. Constant rise in the patients suffering from cardiovascular diseases and is expected to drive market growth during the forecast period.

Governments are trying to limit hospital readmissions to reduce the prevalence of hospital acquired infections (HAIs) by imposing penalties on hospitals. As a result, adoption of home healthcare, remote patient monitoring, and long term care services is rapidly increasing. Thus, demand for cardiovascular devices is increasing from hospitals, patients based in home settings, and long term care centers.

In addition, favorable government policies such as reimbursement coverage are fueling adoption of these devices. Thus, increasing target patient population, rising acceptance of home healthcare, and favorable government policies are some of the major factors driving the growth of the global cardiovascular devices market.

On the other hand, high device cost and stringent regulatory approval procedure are some of the prime factors challenging the growth of the market. In addition, lack of skilled professionals to perform surgical procedures using advanced devices is impeding the adoption of new devices.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/cardiovascular-devices-market

Further key findings from the study suggest:

• Availability of minimally invasive surgical devices coupled with high surgical cost is resulting in higher revenue share of surgical devices. As a result, surgical devices segment dominated the overall market in 2015.
• Diagnostics and monitoring device segment is anticipated to grow at the fastest growth rate of 8.4% during the forecast period. Government initiatives to promote early diagnosis of the diseases, increasing adoption of home healthcare services and long term care centers is primarily affecting the growth of diagnostic and monitoring segment positively.
• North America dominated with market share of 42.3% of the global market in 2015. Presence of large pool of target population, reimbursement coverage and high adoption rate for advanced treatments are some of the factors driving the growth of the cardiovascular devices market in North America.
• Furthermore, favorable government policies and presence of well-defined regulatory framework are some of the factors augmenting the market growth in North America.
• Asia Pacific is anticipated to register significant growth during the forecast period. Growth of the region would primarily attribute to anticipated rise in geriatric population prone to cardiac diseases and booming medical tourism in Asia Pacific.
• Moreover, presence of rapidly developing countries such as India and China are expected to render positive growth to the Asia Pacific market. Government initiatives to improve healthcare infrastructure, increasing healthcare expenditure and increasing demand for advanced healthcare facilities are some of the factors anticipated to push the market in India and China towards swift growth.
• Major players contributing to the global market include, Medtronic plc, Becton Dickinson and Company, Cardinal Health, Inc., Boston Scientific Corporation, B. Braun Melsungen AG and Abbott Laboratories, Inc., Cook Medical, Inc., Terumo Cardiovascular Systems Corporationand St. Jude Medical, Inc.
• Competition among the key players would depend upon several factors included but not limited to manufacturing capacity, strong distribution network, pricing strategy and product innovation

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-cardiovascular-devices-market

Massive growth and business opportunities in Dissolved Gas Analyzer Market

The global dissolved gas analyzer market is estimated to reach a valuation of USD 1.11 billion by 2024 according to a new study by Grand View Research, Inc. The augmented demand to monitor the transformer health in order to increase operational efficiency is expected to significantly fuel the adoption of the product over the forecast period. Dissolved gas analyzers are primarily utilized to identify faults in the power transformers positioned at an early stage. This enables energy companies (utilities) to establish maintenance programs meant for repairing, avoiding faults, and extending the durability of power transformers.

The growing awareness pertaining to the fault probability of high-voltage transformers, paired with the high cost of replacing depreciating transformers, has significantly escalated the product demand. Stringent safety and efficiency regulations imposed by the government of developed countries, such as the U.S., has instigated power transformer users to adopt dissolved gas analyzers. Additionally, the rising adoption of online Dissolved Gas Analysis (DGA), owing to benefits including the remote and continuous monitoring of transformer health, is expected to catapult the market growth over the forecast period.

The Digital Gas Analyzer (DGA) market is characterized by several technological trends. The surging demand for safe power transformers impels industrialists to innovate and find better technological solutions to fulfill the unmet needs of customers. For instance, in February 2013, Qualitrol introduced the new QNet4100 intelligent system for the alarm management and discrete event monitoring. With the widespread adoption of Industrial Internet of Thing (IIoT), a high level of automation may be witnessed in the entire fault detection process in the energy sector. Furthermore, the snowballing deployment of smart grid in the U.S., UK, Germany, China, and India would drive the adoption of gas analyzers to detect fault over the forecast period.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/dissolved-gas-analyzer-dga-market

Further key findings from the study suggest:

• On the basis of extraction type, the headspace extraction segment is anticipated to witness a robust growth at a far exceeding 14% over the forecast period. This can be attributed to the low risk of operator error from excessive handling of the sample during injection and preparation. In addition to this, the advantage of automating the process associated with this technique is also one of the key factors for the growth in the revenue of this particular segment. Vacuum extraction accounted for the majority market share in 2015 owing to the early development of this extraction technique
• The power rating segment comprises 100-500 MVA, 501-800 MVA, and 801-1200 MVA DGA devices. The 100-500 MVA power rating gas analyzers segment accounted for more than 60% of the overall revenue share in 2015 and is estimated to grow at a CAGR of more than 12% over the forecast period. The low price and low maintenance costs associated with these devices are one of the primary factors for the adoption of dissolved gas analyzers with these ratings
• On the basis of analysis type, the laboratory services segment accounted for over 35% of the overall revenue share in 2015. This is primarily attributed to the snowballing R&D investments for developing innovative and efficient methods for aging diagnostics. Furthermore, the growing emphasis by utilities on avoiding failures and lowering the maintenance cost is expected to drive the comprehensive DGA monitoring segment growth over the coming years
• The Asia-Pacific dissolved gas analyzers market is estimated to grow at a CAGR of more than 13% over the next eight years; this is due to the increased government spending in the industrial infrastructure projects as well as power transformers in order to expand the power capacity to meet the electricity shortage particularly across the emerging economies including India, China, and Indonesia. North America is expected to grow at a moderate pace mainly due to the escalating need to detect faults among the newly installed transformers paired with the growing demand for increasing the lifespan of the old transformers
• Notable players in the industry include ABB Ltd., Doble Engineering, General Electric, LumaSense Technologies, Morgan Schaffer Inc., Siemens, and Weidmann. The industry is technology driven and continuously evolving. Prominent industry players invest heavily in R&D activities for new product development and product enhancement in order to gaina competitive advantage.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-dissolved-gas-analyzer-dga-market

Car Rental Market Projected To Reach $119.56 Billion by 2024

The global car rental market is expected to witness a substantial growth over the forecast period, reaching USD 119.56 billion by 2024, according to a new report by Grand View Research, Inc. The industry is primarily driven by the growth as well as expansion of the global travel and tourism industry. There has been a significant increase in the number of business and leisure trips worldwide over the past few years.

The advent of online rental portals has helped shape the dynamics of the car rental industry. Growing usage of smartphones and tablets has helped customers to book and reserve cars from anywhere at any point of time. Major players, such as Enterprise Rent-A-Car and Avis Budget Group, are now focusing on developing smartphone applications and optimizing their customer-friendly websites to facilitate quick and convenient bookings.

However, compliance with stringent vehicle emission regulations is expected to challenge the demand for these services across the world. In addition to this, the instability in crude oil prices and growing demand for public transportation are presumed to challenge the growth to some degree over the forecast period.

Browse Full Overview of Report: http://www.grandviewresearch.com/industry-analysis/car-rental-market-analysis-market

Further key findings from the report suggest:

• An emerging trend in the travel and tourism industry which is gaining immense popularity is the evolution of “Bleisure”, which refers to a combination of leisure travel with business trips. The growth in this trend is presumed to propel the demand for car rentals among businesses as well as leisure travelers.
• Executive cars are expected to witness a considerable growth with an estimated CAGR of close to 7% from 2016 to 2024. Swift globalization culminating into increased business trips across the globe is the primary factor propelling the growth of these cars in the near future.
• In terms of application, airport transport dominated the overall industry share in 2015 and is presumed to retain its dominance over the next eight years. Rapid globalization has resulted in a significant increase in the number of air travelers across the globe, which, in turn, has bolstered the growth prospects of the industry.
• The Asia Pacific market was valued at over USD 12 billion in 2015 and is presumed to witness a substantial growth over the forecast period. The significant regional growth prospects can be attributed to the rising economic development, enhanced road and infrastructure facilities, and growth in tourism over the forecast period.

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-car-rental-market

The Future Market Status of the Breast Imaging Technology

The global breast imaging market is expected to reach USD 7.3 billion by 2024, according to a new report by Grand View Research, Inc. The increasing incidences of breast cancer coupled with the continual product improvements being launched and the numerous R&D innovation initiatives being undertaken in the field of cancer are expected to collectively boost the growth of the market over the forecast period.

In 2012, the WHO estimated that around 53.0% of the global women population (1.8 billion women) is anticipated to suffer from breast cancer over their lifespan. This alarmingly rising rate is expected to be the preliminary driver for this market over the forecast period.

The rising base of the geriatric population is another high impact rendering driver of the breast imaging market. A study by the NCBI (National Center for Biotechnology Information) stated that the incidence of breast cancer is higher in patients above the age group of 45.

Increasing expenditure on R&D coupled with government funding are the other vital factors expected to trigger market growth over the forecast period. In 2013, the National Institute of Health, in the U.S. provided a grant amounting to USD 5.6 billion to conduct research on breast cancer. Digital mammography is one of the technologies gaining popularity as compared to other technologies, which is expected to positively reinforce this market’s growth.

However, the high cost of the existing imaging systems coupled with the stringent regulatory policies governing the approval of new products and marketing are predicted to slowdown growth.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/breast-imaging-equipment-market

Further key findings from the study suggest:

• The 3D tomosynthesis segment is identified as the fastest growing segment. This technology offers enhanced efficiency and higher diagnostic accuracy in comparison to other available technologies, which is expected to aid market growth.
• North America is likely to dominate throughout the forecast period with a revenue share of over 30.0% by 2024.Government initiatives including the precision medicine initiative, started by President Obama in 2015, promotes the development of personalized medicine, which is anticipated to foster market growth.
• Asia Pacific is anticipated to grow at the fastest rate of12.0% over the forecast period. The Increasing number of investments in the healthcare sector coupled with the rising awareness of breast cancer and other associated conditions is anticipated to propel the market growth in this region.
• Some major players of the market are Siemens Healthcare, GE Healthcare, Dilon Technologies, Inc., Hologic, Inc., Gamma Medica, Inc., Fujifilm Holdings Corporation, SonoCine, Inc., Philips Healthcare, Toshiba Corporation, and Aurora Imaging Technology, Inc.
• In order to gain a competitive advantage in the market, the key industry players are adhering to mergers, acquisitions and collaborative agreements. For instance, in January 2016, Gamma Medica, Inc. entered into a contract with Alpha Imaging Technology Corp. for the commercialization of its new product, Luma GEM.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-breast-imaging-equipment 

Blood Gas and Electrolyte Analyzers Market by Product, by Application, By End-use is Expected To Reach USD 653.5 Million In 2022

Global Blood Gas And Electrolyte Market is expected to reach USD 653.5 million by 2022, according to a new study by Grand View Research Inc. Rising number of patients in ICU and critical care units and increasing demand for high throughput and integrated systems are some key factors likely to drive the blood gas and electrolyte analyzers market. Growing global geriatric population base is also expected to significantly contribute towards market growth over the forecast period, by triggering the incidence rates of target diseases and widening the base of patients requiring critical care. Furthermore, the emergence of multi-parameter monitoring devices owing to, expanding test menus and growing demand for portable devices is expected to boost usage rates over the forecast period. The availability of blood gas analyzers has helped enhance the care of critically ill patients allowing for frequent diagnosis and monitoring of respiratory problems and ability to guide prognosis and therapy. Rising demand for technically advanced sleek handheld devices involving short turnaround time has resulted in the development of more compact, sleek, handheld point-of-care devices. For instance, the OPTI CCA-TS2 blood gas and electrolyte analyzers use innovative optical technology and provide fast results while requiring minimal maintenance.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/blood-gas-and-electrolyte-analyzers

Further key findings from the study suggest:

• Portable analyzers dominated the market with a share of over 60.0% in 2014 and are also expected to witness lucrative growth over the forecast period. Growing demand for automated, self-monitoring, portable devices, shorter analysis time, and quick accurate results are key factors boosting the growth of this segment.
• Combined blood gas and electrolyte analyzers are expected to rapidly gain market share over the forecast period. Rising need for analyzers, which can analyze blood and electrolyte samples together are swiftly gaining popularity among users.
• North America accounted for more than 40% of the blood gas and electrolyte analyzers market in 2014. Presence of sophisticated healthcare infrastructure along with favorable reimbursement plans are some key factors expected to drive regional market growth.
• Presence of high unmet needs clubbed with rapidly improving healthcare infrastructure in the emerging markets of India and China is expected to help Asia Pacific grow at a lucrative rate throughout the forecast period. Growing demand for decentralized point-of-care diagnostic facilities handling large volumes of diagnostic tests is also expected to drive regional market growth.
• Key players of the blood gas and electrolyte analyzers market include Siemens, Medica, Roche, Nova Stat, Bayer, Radiometer Medical, Convergent technologies, Dalko Diagnostics, Afford Medical Technologies, and Accurex Biomedical Pvt. Ltd.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-blood-gas-and-electrolyte-analyzers-market 

Biopreservation: Global Market to Grow at High CAGR in Upcoming Years – 2022

The global biopreservation market is expected to reach USD 9.34 billion by 2022, according to a new report by Grand View Research Inc. Increasing demand for novel bio-preservation techniques and constantly rising healthcare expenditure is expected to boost the market growth over the forecast period. Adoption of in-house sample storage system by hospitals, biotechnology and pharmaceutical companies is one of the critical success factors for the growth of the industry over next seven years.

Additionally, increasing R&D investments by various research organizations and companies to enhance their capabilities to render efficient and effective products & services is a high impact rendering driver expected to boost bio-preservation market growth. Furthermore, as a consequence of technological advancements such as introduction of virtual bio-banks, bio-preservation is witnessing increased application in end-use hence boosting the growth of bio-preservation market.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/biopreservation-market

Further key findings from the report suggest:

• Equipment dominated the overall product segment in 2014, with the revenue share of over 80%. Key factors attributing to its large share include rising demand of bio-banks coupled with high cost for preservation of bio-specimens.  
• Media, which encompasses pre-formulated and home-brew media is expected to witness high growth over the forecast period as a consequence of their wide usage in regenerative medicines.
• Bio-banking dominated was the key application segment of bio-preservation in 2014, with lucrative market share owing to increasing number of organ and tissue transplantations, high patient awareness levels and rise in healthcare expenditure.
• Regenerative medicine is estimated to grow at a rate of over 18% as a result of huge investments made by government, and non government organizations in the field of regenerative cell therapy research.
• Tumor cells held the largest share in volume terms in 2014, owing to their wide applications in research & development, diagnosis, and treatment of highly prevalent cancer.
• North America dominated the overall industry in 2014 with over 45% revenue share majorly due to favorable government regulations in North America which are supporting the ethical usage and sharing of biological samples.
• Asia Pacific is expected to grow at substantial rate during the forecast period as a consequence of high unmet needs amongst the population in the region coupled with constantly improving healthcare infrastructure as a result of government initiatives such as Make In India.
• Key players of the bio-preservation market include BioCision, Biomatrica, BioLife Solutions Inc., Chart MVE Biomedical, LabVantage Solutions Inc., Atlanta Biologicals, Panasonic Biomedical, Thermo Fisher Scientific Inc. and Qiagen. These companies are involved in various developmental strategies such as mergers and acquisitions to sustain their market share.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-biopreservation-market-analysis 

Biodegradable Mulch Films Market Outlook - World Agriculture Supply and Demand Estimates Report

The global biodegradable mulch films market value is expected to reach USD 64.3 million by 2024, according to a new report by Grand View Research, Inc. Growing population coupled with depleting arable land is anticipated to drive the market growth over the next eight years. Biodegradable mulch films are used to enhance crop quality by suppressing weed growth and maintaining soil temperature. 

Biodegradable mulch films have a lower environmental impact as they do not produce any harmful waste, and their disposal is easy. Government regulations promoting bio-based product usage, especially in Europe and North America is expected to drive market growth over the foreseeable future. Key players in the industry have been investing in R&D to develop fully bio-based mulch films. 

Fruits & vegetables emerged as the leading crop using biodegradable mulch films and accounted for 51.1% of total market revenue in 2015 and is also anticipated to witness the fastest growth over the next eight years. The high growth may be attributed to biofilm ability to prevent fruits from rotting by preventing contact between fruit and soil. 

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/biodegradable-mulch-films-market

Further key findings from the report suggest:

• Thermoplastic starch (TPS) was the leading raw material in 2015 and is expected to reach a market worth USD 47.3 million by 2024, growing at a CAGR of 7.7% from 2016 to 2024. The high demand may be attributed to the easy availability of starch at low prices coupled with an inability to produce any harmful products when placed in soil.
• Starch blended with polylactic acid (PLA) is also expected to witness a brisk growth over the forecast period. The high growth may be attributed to their advantage of being produced from 99% biobased material coupled with growing PLA films demand particularly in Europe.
• Asia Pacific was the major consumer and accounted for 64.1% of global revenue in 2015 and is expected to witness the fastest growth in the biodegradable mulch film market over the next eight years owing to growing industrialization resulting in rising food demand.
• Major companies operating in the global biodegradable mulch film industry include Kingfa Sci & Tech Co Ltd, Al-Pack Enterprises Ltd, BioBag International AS, RKW SE, AEP Industries Inc, BASF, Novamont, British Polythene Industries PLC, Armando Alvarez and Ab Rani PlastOy. Major companies have been adopting various strategies such as M&A, joint ventures, new product development and capacity expansions to increase their market share.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-biodegradable-mulch-films-market

Automotive Refinish Coatings Market Worth $14.88 Billion By 2024

The global automotive refinish coatings market is expected to reach USD 14.88 billion by 2024, according to a new report by Grand View Research, Inc. Rising demand for automotive refinish coatings as they improve the durability and enhance the appearance of vehicles will fuel market growth over the next eight years. Furthermore, aging of vehicles, rising demand for repair, maintenance, and aftermarket modifications will augment product demand over the forecast period. 

The waterborne technology was valued at USD 3.40 billion in 2015 and is expected to witness significant rise on account of excellent heat resistance, adhesion, and abrasion properties. Furthermore, its advantage over solvent borne coatings including less toxicity, less flammability, and reduction of air emissions will propel market growth over the forecast period. 

The basecoat is expected to witness significant revenue rise at a CAGR of 6.9% from 2016 to 2024 over the forecast period as it provides color, decorative effects and exterior aesthetic to vehicles.Increasing demand for solid basecoats in motorcycles, trucks and cars owing to the ease of application coupled with basic color effect will increase industry size. 

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/automotive-refinish-coatings-market

Further key findings from the report suggest:

• Global automotive refinish coatings market demand was 916.4 kilo tons in 2015 and is expected to witness high gains in light of growing vehicle sales in China, India, and Mexico
• Acrylics was a prominent segment and accounted for 21.1% of the overall volume in 2015. The product will show growth in light of its high usage in waterborne technology. Furthermore, superior properties including resistance to stain, blistering, cracking, and extreme temperatures will fuel its demand over the forecast period.
• North America accounted for 22.8% of the global revenue share in 2015 and is expected to witness significant gains in light of growing need for repair, maintenance, and customization over the upcoming years.
• Latin America will witness significant revenue growth at a CAGR of 6.6% from 2016 to 2024 as a result of increasing automotive vehicle sales in Argentina, Brazil, and Columbia. Prevalence of road accidents along with the growing trend of recreational vehicles in Brazil will fuel industry expansion.
• Automotive refinish coatings industry is dominated by key participants including BASF, Axalta Coating Systems, PPG Industries, AkzoNobel, and Sherwin-Williams. Ongoing product development by various companies to manufacture high-performance and cost-efficient coatings is expected to augment product consumption over the next eight years.
• In December 2015, PPG Industries in collaboration with Asian Paints introduced product line of environment base high performance waterborne automotive refinished paint in Sri Lanka to expand the customer base

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-automotive-refinish-coatings-market 

Automotive Sensors are Good investment for Business in upcoming years

The Global Automotive Sensor Market size is expected to reach USD 36.76 billion by 2022, according to a new study by Grand View Research, Inc. Favorable government regulations for increasing overall passenger security and safety is expected to augment market demand over the forecast period. These products have become an important part of automobiles, and detect physical parameters such as speed and heat and take preventive measures in case of any danger.

Growing consumer adoption of electric, hybrid and hydrogen fuel-cell-powered motor vehicles is expected to drive demand for battery monitoring. Image sensor-based ADAS systems have become essential for tracking and identifying potential hazards. Additionally, rising number of autonomous vehicles in yielding lower fuel consumption and reduced traffic congestion features in developing countries such as Japan and China is expected to favorably impact the automotive sensor market. Demand for retrofitting of advanced systems into the existing motor vehicle fleet is also expected to augment demand.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/automotive-sensors-market

Further key findings from the study suggest:

• Advanced proximity and positioning sensors help remotely determine the location of an object, and this segment is expected to grow at a CAGR of over 11.0% from 2015 to 2022. These products include radar, infrared, ultrasonic, and laser devices, and are finding application in detection of objects around vehicles in addition to occupancy sensing.
• Sensors used for safety and security applications monitor wheel speed, occupant position tire inflation, etc. For instance, Jaguar F-type uses these products for blind spot monitoring and close vehicle sensing designed to alert the driver about the presence of another vehicle in an adjacent lane by providing a visual warning indicator in the door’s mirror.
• Asia Pacific is expected to remain the leading regional market through the forecast period. The North American automotive sensor market is characterized by the presence of a stringent regulatory landscape. The U.S. NHTSA is attempting to control driver support technologies and direction of automotive collision avoidance. The government is expected to mandate fitment of V2V safety technology in future cars. In addition, the U.S. Association of Automobile Manufacturers (AMM) is expected to leverage rear-view camera and removing side-view mirrors, which can reduce noise and fuel consumption. Outsourcing of manufacturing process to low-cost countries like Mexico, China, Bulgaria, Malaysia, India or the Dominican Republic due to high labor costs in the U.S. is a key industry trend.
• Major industry participants such as Bosch focus on research and development to ensure product differentiation. The company’s R&D efforts have focused on development of efficient methods for ensuring reliability, precise 3D environment recognition, and securing the electronics architecture through constant plausibility checks on the data supplied. Other key players such as Freescale, Sensata, and Denso Corporation provide products that cater to a wide range of applications, such as ADAS, body electronics, chassis and safety, etc.

Browse Press Release of this Report: http://www.grandviewresearch.com/press-release/global-automotive-sensors-market

Automotive Lighting Market is Anticipated to Reach $34.65 billion by 2022

The automotive lighting market is anticipated to reach USD 34.65 billion by 2022. Strict government policies and rising safety concerns are likely to propel growth over the forecast period. In addition, growing consumer awareness concerning the significance of adaptive lighting including dynamic bend light and a glare-free high beam is also expected to have a positive impact on the exterior lighting market. 

Increasing apprehensions about using energy efficient methods coupled with rising consumer disposable income are expected to drive the industry. In addition, growing demand for vehicles and technological advancements in the automotive industry are expected to propel utilization. Attractive growth opportunities for new entrants are expected in the industry owing to the growing number of total vehicles purchased y-o-y across BRIC nations. However, there is a need for legislative authorities to collaborate with light sourcing technology suppliers to develop flexible design techniques. 

Automotive LED market is estimated to demonstrate considerable growth at a CAGR of over 12.0% from 2015 to 2022. Halogen lights contributed to over 66.0% of overall industry revenue in 2014, followed by LED and xenon. It has gained prominence on account of easy availability, low purchasing costs, and low replacement costs. However, rising fuel prices are expected to pose a threat to the industry. 

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/automotive-lighting-market

The increase in demand for eco-friendly LED technologies on account of high efficiency, reduced CO2 levels, and high power, is expected to propel growth. Companies have been trying to develop eco-friendly LED to promote product differentiation and strengthen their global foothold. LEDs are used in daytime running lights (DRL), parking light, brake lights and turning lights. LEDs are preferred over xenon and halogen lights owing to optimum light bearing capacities and improved design which lead to increased shelf life. 

The adaptive headlight is an active safety feature that is intended to enhance the drivers’ visibility in poorly illuminated areas. It encompasses functionalities including automatic rotation which can sync with sensors and adjust brightness and intensity of light. Front lighting segment constituted for over 70.0% of the total revenue in 2014 owing to the availability of advanced features including automatic rotation which can sync with automatic brightness modules and sensor response. Extreme climatic conditions in Europe and North America are expected to trigger demand for fog lights over the forecast period. 

Automotive lighting industry in Asia Pacific is estimated to grow at a CAGR of over 8.0% and acquire a market share of about 45.0% over the forecast period. The continuous expansion of suppliers coupled with a vast production base is expected to position this region as the market leader. Countries including India, Japan, and China account for the major production base for vehicles globally, thus offering extensive growth opportunities. 

Key companies including Hella KGaA Hueck & Co., Koito Manufacturing Co., Magneti Marelli S.p.A and Valeo. Vendors usually employ the strategy of new product development and mergers & acquisitions to enter new markets. The introduction of low-cost LEDs and energy-efficient alternatives is foreseen as a cost-effective strategy for the industry.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-automotive-lighting-market

Automotive Lighting Market is Anticipated to Reach $34.65 billion by 2022

The automotive lighting market is anticipated to reach USD 34.65 billion by 2022. Strict government policies and rising safety concerns are likely to propel growth over the forecast period. In addition, growing consumer awareness concerning the significance of adaptive lighting including dynamic bend light and a glare-free high beam is also expected to have a positive impact on the exterior lighting market. 

Increasing apprehensions about using energy efficient methods coupled with rising consumer disposable income are expected to drive the industry. In addition, growing demand for vehicles and technological advancements in the automotive industry are expected to propel utilization. Attractive growth opportunities for new entrants are expected in the industry owing to the growing number of total vehicles purchased y-o-y across BRIC nations. However, there is a need for legislative authorities to collaborate with light sourcing technology suppliers to develop flexible design techniques. 

Automotive LED market is estimated to demonstrate considerable growth at a CAGR of over 12.0% from 2015 to 2022. Halogen lights contributed to over 66.0% of overall industry revenue in 2014, followed by LED and xenon. It has gained prominence on account of easy availability, low purchasing costs, and low replacement costs. However, rising fuel prices are expected to pose a threat to the industry. 

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/automotive-lighting-market

The increase in demand for eco-friendly LED technologies on account of high efficiency, reduced CO2 levels, and high power, is expected to propel growth. Companies have been trying to develop eco-friendly LED to promote product differentiation and strengthen their global foothold. LEDs are used in daytime running lights (DRL), parking light, brake lights and turning lights. LEDs are preferred over xenon and halogen lights owing to optimum light bearing capacities and improved design which lead to increased shelf life. 

The adaptive headlight is an active safety feature that is intended to enhance the drivers’ visibility in poorly illuminated areas. It encompasses functionalities including automatic rotation which can sync with sensors and adjust brightness and intensity of light. Front lighting segment constituted for over 70.0% of the total revenue in 2014 owing to the availability of advanced features including automatic rotation which can sync with automatic brightness modules and sensor response. Extreme climatic conditions in Europe and North America are expected to trigger demand for fog lights over the forecast period. 

Automotive lighting industry in Asia Pacific is estimated to grow at a CAGR of over 8.0% and acquire a market share of about 45.0% over the forecast period. The continuous expansion of suppliers coupled with a vast production base is expected to position this region as the market leader. Countries including India, Japan, and China account for the major production base for vehicles globally, thus offering extensive growth opportunities. 

Key companies including Hella KGaA Hueck & Co., Koito Manufacturing Co., Magneti Marelli S.p.A and Valeo. Vendors usually employ the strategy of new product development and mergers & acquisitions to enter new markets. The introduction of low-cost LEDs and energy-efficient alternatives is foreseen as a cost-effective strategy for the industry.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-automotive-lighting-market

Automated Test Equipment Market is expected to reach USD 4.48 billion by 2020

The Global Automated Test Equipment Market is expected to reach USD 4.48 billion by 2020, according to a new study by Grand View Research, Inc. Increased demand for consumer electronics is expected to drive the market over the forecast period. Increased design complexity due to adoption of system on chip has resulted in need for effective testing, which is expected to favorably impact the market.

Fluctuating demand for semiconductors is expected to pose a challenge to the growth of this market due to its adverse effects on the profitability of industry participants. Consolidated nature of the market may prove to be a barrier for industry growth. Expansion of wireless networks and significant developments in the manufacturing process of semiconductors are factors conducive for market growth over the next six years.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/automated-test-equipment

Further key findings from the study suggest:

• Non-memory ATE dominated the global market and accounted for over 75% of the overall market share in 2013. This is primarily due to increased proliferation of smartphones into the market, expansion of Long Term Evolution (LTE) wireless communication standard, increased automotive demand, and growing number of microcontroller-based applications.
• IT & telecommunication accounted for over 50% of the overall market share in 2013, which can be attributed to the proliferation of computers, smartphones and tablets in the market and increased emphasis on effective communication. Automotive application sector is expected to witness significant growth owing to increased integration of sophisticated electronic devices in automobiles.
• Asia Pacific is expected to be the market leader over the next six years, and accounted for over 70% of the market in 2013, owing to the presence of large number of semiconductor industries in the region and rapid technological advancements. RoW is expected to witness significant growth over the forecast period.
• Key industry participants include National Instruments Corp., LTX-Credence Corporation, Agilent Technologies Inc., Cal-Bay Systems, Aeroflex Inc., Anritsu Co., SPEA S.p.A, Advantest Corporation, Teradyne Inc., Advint LLC, and Rohde & Schwarz GmbH & Co. KG among others.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-automated-test-equipment

New market opportunities for Pneumatic Nebulizers Manufacturers

The global pneumatic nebulizers market was valued at USD 490.6 million in 2015 and is expected to reach a value of USD 893.9 million by 2025. The expansion is attributed to the increasing geriatric population base along with the growing need for home healthcare portable devices. The introduction of new systems featuring aerosol drug delivery technology with minimal drug wastage is expected to drive the market growth. For instance, in May 2013, Parion Sciences in partnership with Cambridge Consultants developed a technology that delivers tiny saline droplets that infiltrate deep into the lungs. The trans-nasal pulmonary aerosol delivery device currently undergoing clinical trial is intended for the treatment of cystic fibrosis.

Moreover, with the rising rate of hospital admissions and the resultant high expenditure, companies are encouraged to introduce home care devices that enable pre-hospitalization monitoring. Furthermore, the advent of integrated devices has empowered patients and physicians to share and access data on a single platform.

For instance, in March 2016, Philips received 510 (K) clearance for its Care Orchestrator. The cloud-based technology is a clinical management software, which promotes homecare for sleep apnea and respiratory care patients. Moreover, the clinical management system furnishes a single platform combining sleep and respiratory care, providing informatics and workflow intelligence for patients, providers, and payers.

Some of the major players operating include Omron Corporation, Philips Healthcare; PARI Pharma GmbH; GE Healthcare; Allied Healthcare; Becton, Dickinson and Company; Agilent Technologies; Medline Industries, Inc.; and Briggs Healthcare.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/pneumatic-nebulizer-market

Further Key Findings from the Study Suggest:

• Vented nebulizers dominated the product type segment in 2015 owing to their high availability and affordable cost. Moreover, industry contributors are introducing new solutions that enable patient data access in one single platform. In November 2015, CareFusion introduced a new respiratory solution at the American Association for Respiratory Care Congress.
• North America is estimated to dominate the pneumatic nebulizers market in 2015. The introduction of advanced technological devices and the supportive medical coverage offered in this region is expected to further fuel market growth. For instance, in March 2015, Sunovion Pharmaceuticals, Inc. announced the initiation of Phase III clinical trial for its SUN-101 solution using PARI Pharma’s eFlow nebulizer system for COPD.
• Asia Pacific is the fastest growing market owing to its huge aging population base, increasing focus on preventive care, and government initiatives promoting technological innovations. In July 2015, Tribeca Care launched its online healthcare store to supply homecare respiratory products, wherein prominent medical brands such as Philips, Omron, Nidek, Karma, ResMed, and Vissco were brought under one roof.
• Sector players are integrating healthcare with technology to improve upon the current patient monitoring devices in the vertical for respiratory diseases. Moreover, increasing awareness around pre-assessment devices has further accelerated the demand for pneumatic nebulizers. In June 2016, Philips introduced the Patient Adherence Management Service at the 2016 SLEEP event to better patient compliance to sleep therapy.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-pneumatic-nebulizer-market 

All Things you want to Know About Medical Holography Market

The medical holography market is expected to reach USD 4.04 billion by 2025, according to a new study by Grand View Research, Inc. The medical holography market is predominantly driven by the increasing penetration of holographic displays in diagnostic imaging for educational and training purposes due to the generation of high quality 3D images, which provide a better insight into disease progression.

The unprecedented penetration rate of holography products is attributable to the inherent benefits of this technology over conventional alternatives, which influence companies to work further toward developing these products for subsequent commercialization.

Furthermore, the high physician demand to gain deep insights during diagnosis is widening the scope for sector growth. In addition, heightening technological sophistication is presumed to accentuate the market uptake of holography products and encourage high participation by the companies.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/medical-holography-market

Further Key Findings from the Study Suggest:

• In 2015, holographic displays accounted for the dominant share in the product segment owing to surging demand for precision in assisted surgeries. In addition, consistent advancements in this field are presumed to further present this segment with opportunities in the future. For instance, in December 2014, Bristol University developed a touchable holographic display through the generation of air disturbances using ultrasound to create 3D haptic shapes
• Medical imaging is expected to grow at a constant rate during the forecast period due to the consistent efforts of major companies to promote the incorporation of holographic products in clinical applications. For instance,in October 2014, Zebra Imaging entered into a partnership with Zygote Media Group to develop advanced 3D biomedical models to visualize human anatomy
• In 2015, North America held a substantial share of the overall market with a share of over 38.0%. This is attributed to the consistent number of investments in the R&D sector. Consequently, the technological advances in the medical holography market space has led to a significant increase in the adoption of these products owing to the better diagnostic outcomes
• Asia Pacific is anticipated to exhibit an exponential CAGR of over 32.0% during the forecast period. The lucrative growth rate is attributable to the rising healthcare spending, consistently growing healthcare infrastructure, and growing awareness levels with respect to the usage of holography products in medical applications
• The key players are consistently undertaking new product development and collaborative strategies to attain a higher market share and gain a competitive position in this sector. For instance, in October 2013, RealView Imaging Ltd. and Royal Philips completed an assessment of live 3D holographic imaging, which facilitates 3D interaction and facilitates minimally-invasive structural heart disease procedures

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-medical-holography-market

Massive Growth and Business Opportunities in Laboratory Informatics Market

The global laboratory informatics market was valued at USD 2.15 billion in 2015 and is expected to reach a value of USD 3.83 billion by 2025. Increasing requirement for life sciences companies to comply with regulatory demands has further promoted the incorporation of laboratory information management systems (LIMS) as it helps professionals understand and fulfill the complex regulatory obligations. Furthermore, demand for cost-efficient workflow management systems is anticipated to drive the growth over the forecast period.

Rising adoption of LIMS solutions by biobanks coupled with the increasing demand for integrated healthcare solutions is the key contributing factor for the growth of the laboratory informatics market over the forecast period. In addition, growing awareness levels amongst the end-use segments and technological evolution of LIMS solutions are anticipated to fuel the growth in the coming years.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/laboratory-informatics-market

Further key findings from the report suggest:

• LIMS dominated the overall laboratory informatics market on the basis of technology in 2015 owing to the associated benefits such as data tracking and management with fewer errors. Moreover, demand for fully integrated LIMS platforms is growing in accordance with the requirements of life sciences and research industries to reduce the incidence of errors in data management and qualitative analysis of research information. The above-mentioned factors are expected to drive the segment growth.
• On the other hand, demand for upgraded laboratory informatics technologies such as electronic lab notebook and Enterprise Content Management (ECM) solutions amongst research professionals and industry players, respectively, is expected to increase over the forecast period. Associated benefits of ECM, such as database management of large unstructured or structured medical information and supportive government initiatives, are expected to contribute to its lucrative growth over the forecast period.
• Cloud-based services are anticipated to show lucrative CAGR over the forecast period due to its growing acceptance by industry participants. The introduction of technologically advanced software solutions and their widespread adoption by the healthcare IT providers are expected to impede the growth of the on-premise segment over the forecast period. Furthermore, advantages associated with its usage, including remote access to information, reduced operational cost, and real-time data tracking, are contributing toward their rising demand.
• North America dominated the market as of 2015, which is attributable to supportive government initiatives promoting the adoption of LIMS. On the other hand, the Asia Pacific market is likely to exhibit profitable growth due to increasing R&D expenditure deployed by the public and private sectors coupled with increasing awareness levels pertaining to LIMS
• The key players serving laboratory informatics market are Thermo Fisher Scientific, Inc., Core Informatics, LabWare, Cerner Corporation, PerkinElmer, Inc., LabVantage Solutions, Inc., LabLynx, Inc., Agilent Technologies, ID Business Solutions Ltd., McKesson Corporation, Waters Corporation, and Abbott Informatics.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-laboratory-informatics-market 

Recent Trends in Bisphenol A Market for Future Business Opportunity

The global market for Bisphenol A (BPA) is expected to reach USD 20.03 billion by 2020, according to a new study by Grand View Research, Inc. BPA is largely used for the production of polycarbonates and growing demand of polycarbonates in consumer goods and medical devices is expected to be a key driver for the market. In addition, the growing construction industry and growing BPA demand in automobile industry are expected to further augment market growth. However, health hazards associated with the use of BPA resulting in regulatory pressure is expected to be a key challenge for the industry over the next six years.

Polycarbonate was the largest application segment accounting for 5,083.5 kilo tons of BPA demand in 2013; followed by epoxy resin applications, with market volume estimated at 1,414.7 kilo tons in 2013. Superior performance of epoxy resins, in terms of thermal stability, corrosion protection and mechanical strength for industrial applications is expected to reflect in BPA demand; as a key monomer for these resins.

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/bisphenol-a-bpa-market

Further key findings from the study suggest:

• The global demand for BPA was 7,000.9 Kilo tons in 2013 and is expected to reach 9,618.7 Kilo tons by 2020, growing at a CAGR of 4.7% from 2014 to 2020.
• Asia Pacific was largest regional market for BPA with 54% of market share and revenue of USD 7.00 billion in 2013. This was owing to the presence of large number of end-user industries coupled with low labor, raw material and operating cost in the region. In addition, many conglomerates have shifted their base to Asia Pacific on account of the aforementioned reasons.
• North America and Europe are expected to witness below average growth, at an estimated CAGR of 4.5% and 4.3% respectively from 2014 to 2020. Governments of Canada and European Union have banned the use of polycarbonate’s derived products resulting in decreased demand for BPA.
• The global BPA market is somewhat fragmented with top four companies accounting for less than 45% of the market in 2013. Key companies in the market include Bayer Material Sciences, Dow Chemicals, SABIC Innovative Plastics and Mitsui Chemicals among others.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-bisphenol-a-bpa-market

Biofertilizers Market is Expected to Reach USD 1.65 Billion by 2022

Global biofertilizers market is expected to reach USD 1.65 billion by 2022, according to a new study by Grand View Research, Inc. The industry is expected to witness significant gains over the next seven years owing to rising need for feasible eco-friendly solution for plant and soil growth. 

Emergence as drop in replacements for chemical fertilizers on account of environment friendly properties and similar applications is expected to promote growth. Stringent regulations coupled with government initiatives supporting biofertilizers use is a primary reason for perpetuating growth over the past few years. 

Favorable government support for use of eco-friendly products and increasing production output of organic foods is expected to augment market growth in North America and Europe over the forecast period. 

Fluctuating chemical prices coupled with commercial response to growing food cost is expected to be one of the key drivers for the market over the next seven years. Growing need for high agricultural yield in order to meet increasing population needs has triggered products use on account of low environmental impact.  

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/biofertilizers-industry

Further key findings from the study suggest:

• Phosphate solubilizing biofertilizers market is expected to grow at the fastest CAGR of 13.9% from 2015 to 2022. These include bacillus, pseudomonas and aspergillums bacteria which provide phosphorous macronutrients to plants. Soluble bacteria in the product impart superior characteristics and are the key reason for high growth expectation over the forecast period.
• Soil treatment accounted for over 30.0% of global market revenue in 2014 and is expected to grow at a CAGR of 13.0% from 2015 to 2022. Rising awareness towards deployment of eco-friendly products for increasing crop yield is expected to augment product demand.
• North America biofertilizers market was the largest in terms of revenue accounting for over 32.0% in 2014 on account of numerous manufacturers in the region. Positive agriculture industry outlook in the U.S. and Canada along with increasing awareness regarding the application of eco-friendly products in farming is expected to have favorable impact for biofertilizers market.
• Some of the key biofertilizer manufacturers include CBF China Bio-fertilizer AG, Novozymes A/S, Antibiotice S.A, AgriLife, and Symborg S.L. In January 2011, CBF China Bio-fertilizer built a new production line in the Shandong plant with an additional capacity of 10,000 tons. Novozymes’ new enzyme technology is known to produce high yields of corn oil and ethanol along with energy savings during production.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-biofertilizers-market

Global Biosimulation Market is Growing At a Rapid Pace - Market Analysis and Forecast to 2024

The biosimulation market is expected to reach USD 3.77 billion by 2024, according to a new study by Grand View Research, Inc. The unprecedented global shift in the adoption of unhealthy lifestyles is resulting in the high prevalence of chronic diseases, such as cancer and diabetes, is expected to drive the biosimulation market during the forecast period. In addition, the rising geriatric population base highly susceptible to acquire the fore mentioned chronic diseases result in enhanced demand for highly efficacious pharmacological drugs. This high requirement of efficacious drugs can be effectively met at a faster rate through the incorporation of the in silico approach, thus creating a high potential for biosimulation market growth opportunities in the future. Furthermore, increasing drug resistance, high drug failure rate, and availability of limited drugs to treat several diseases such as AIDS, pneumonia, tuberculosis, and others indicate the indisputable requirement for the incorporation of biosimulation in the drug discovery and development process. The widespread application of the in silico approach to developing efficacious drugs would generate drugs of greater potency in the market within a shorter span.

The increasing demand can be attributed primarily to the significant cost reduction in the clinical trials and drug development & discovery process. This is due to the fact that the in silico software can predict adverse reactions, toxicity, and efficacy of the drugs in the early stages of the drug development, thereby reducing the probability of drug failure at the later stages and consequentially, control the overall expenditure. These above-mentioned factors serve as key reasons responsible for the heightened market demand.

Browse Full research report on Biosimulation Market Analysis:
http://www.grandviewresearch.com/industry-analysis/biosimulation-industry

Further key findings from the study suggest:

• The services segment is expected to exhibit growth at a significant CAGR of over 16.0% during the forecast period. This is a consequence of rising inclination of the big pharmaceutical companies to outsource their biosimulation process so as to reduce the overall cost incurred in research and development and divert its focus toward their core capabilities.
• The drug discovery segment is anticipated to witness an exponential CAGR of over 15.0% in the application segment. Associated benefits of biosimulation in drug discovery are anticipated to fuel the demand over the forecast period. These benefits include the elimination of potential drug failures, predict unfavorable drug interactions, and anticipate potential risks.
• In addition to these, certain other advantages include increased drug efficacy through the evaluation of optimal synergistic combinations, enable study of the mechanistic actions of drugs, and identification of the most suitable dosage forms, which render the drug discovery segment a profitable zone.
• In 2015, the pharmaceutical and biotechnology companies held a substantial share of this vertical of over 58.0% in 2015. This can be attributed to the consistent efforts of these companies to develop better medication options at a faster and cheaper rate through in silico biology techniques.
• Likewise, the academic research applications are presumed to witness constant growth as a consequence of the presence of various academic research groups that are involved in the study of complex biological systems using computer models, such as by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
• In 2015, North America dominated the overall biosimulation market at over 50.0%. The presence of regulatory authorities, consistently inclined towards ensuring patient safety, is a crucial factor presumed to be responsible for the dominant market share of this region. Moreover, the presence of highly skilled professionals also serves as a significant growth driver.
• The numerous collaborations amongst the leading players that are being undertaken to promote the incorporation of biosimulation systems are expected to be responsible for bolstering the growth in this region. For instance, Entelos, Inc. collaborated with Bayer AG to develop novel gene-based drug targets and also with Johnson & Johnson, Inc. to optimize clinical trial designs through in silico models.
• Some of the leading players in this industry include Certara USA, Inc., Simulation Plus, Inc., Dassault Systems SA, Rhenovia Pharma Ltd., and Evidera, Inc. These players are actively involved in initiating collaborative strategies and frequent product launches to capture a larger share of the vertical.For instance, In April 2016, Simulation Plus, Inc. launched the DDDPlus Version 5.0, invitro dissolution experiment software. This upgraded version includes improvements in functionalities of the software that enable scientists and researchers to study the behavior of different pharmaceutical dosage forms.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-biosimulation-market

Key factors that drive and impede the growth of World Bioherbicides Market

The global bioherbicides market is expected to reach USD 4.14 billion by 2024, according to a new report by Grand View Research, Inc. Growing eco-friendly weed killer demand on account of increasing organic farming preference over synthetic methods is expected to remain a key driving factor for global bioherbicides market. In addition, sustainable crop cultivation practices development is also anticipated to positively influence the market growth. High quality and nutritional fruit & vegetable cultivation with the help of bioherbicides are expected to significantly contribute towards industry development. 

The shift in consumer’s trend towards nutritional and greener diet has given rise to organically produced vegetables and food grains demand which in turn is anticipated to drive industry growth over the forecast period. Easy availability coupled with affordable prices of synthetic herbicides is expected to a pose challenge to bioherbicides market. In addition, lack of awareness among farmers is also anticipated to negatively impact the product preference for cultivation purposes. 

Fruit and vegetable sector was the leading application segment and accounted 27.3% of total revenue in 2015. Turf and ornament segment is anticipated to witness the highest growth of 16% from 2016 to 2024. The product finds its application in gardening, clearing of railway tracks, gold course maintenance which is anticipated to further contributed expand the application base in turf and ornament sector. 

To request a sample copy or view summary of this report: 
http://www.grandviewresearch.com/industry-analysis/bioherbicides-market

Further key findings from the report suggest:

• Global bioherbicide market was valued at USD 1.12 billion in 2015 and is expected to reach USD 4.14 billion by 2024, growing at a CAGR of 15.7% from 2016 to 2024
• North America was the leading regional market and accounted for 29.5% of global revenue in 2015. Government initiatives and increasing consumer awareness regarding health and environmental issues particularly in the U.S. are expected to drive the regional market over the forecast period.
• Asia Pacific is expected to witness the highest growth of 16.1% from 2016 to 2024. Increasing product demand in Australia is anticipated to significantly contribute to the overall regional growth.
• Key players operating in the global bioherbicides industry include Bioherbicides Australia (BHA), Hindustan Biotech, Marrone Bio Inventions, Fitz Chem Corporation, Emery Oleochemicals, Mycologic Inc and Engage Agro USA.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-bioherbicides-market